(Q45862369)

7 June 2018

title

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers (English)

1 reference

7 June 2018

Cristian Rodriguez-Aguayo

1 reference

Ivan Vannini

8

0 references

Cristian Rodriguez-Aguayo

5

0 references

Cristina Ivan

Cristina Ivan

4

0 references

Antonino Neri

Antonino Neri

18

0 references

Hagop Kantarjian

35

Hagop M Kantarjian

1 reference

7 June 2018

27

Alessandra Ferrajoli

1 reference

7 June 2018

40

George A Calin

1 reference

7 June 2018

39

Muller Fabbri

1 reference

7 June 2018

38

Michael J Keating

1 reference

7 June 2018

29

William Plunkett

1 reference

7 June 2018

34

Ignacio I Wistuba

1 reference

7 June 2018

28

Robert Orlowski

1 reference

7 June 2018

Q108934199

9

Roxana S Redis

1 reference

7 June 2018

Q110371887

24

Steliana Calin

1 reference

7 June 2018

Ioana Berindan-Neagoe

32

Ioana Berindan-Neagoe

1 reference

7 June 2018

Anil K. Sood

36

Anil K Sood

1 reference

7 June 2018

Gabriel Lopez-Berestein

37

Gabriel Lopez-Berestein

1 reference

7 June 2018

Vianey Gonzalez-Villasana

14

Vianey Gonzalez-Villasana

1 reference

7 June 2018

Xinna Zhang

11

Xinna Zhang

1 reference

7 June 2018

Milena S Nicoloso

12

Milena S Nicoloso

1 reference

7 June 2018

Chad V Pecot

21

Chad V Pecot

1 reference

7 June 2018

Lianchun Xiao

7

Lianchun Xiao

1 reference

7 June 2018

Francesca Fanini

2

Francesca Fanini

1 reference

7 June 2018

Katrien Van Roosbroeck

1

Katrien Van Roosbroeck

1 reference

7 June 2018

Enrique Fuentes-Mattei

6

Enrique Fuentes-Mattei

1 reference

7 June 2018

Rajesha Rupaimoole

15

Rajesha Rupaimoole

1 reference

7 June 2018

Manuela Ferracin

16

Manuela Ferracin

1 reference

7 June 2018

Dino Amadori

22

Dino Amadori

1 reference

7 June 2018

Ramana V Davuluri

31

Ramana V Davuluri

1 reference

7 June 2018

Lynne V Abruzzo

23

Lynne Abruzzo

1 reference

7 June 2018

Peter P Ruvolo

19

Peter P Ruvolo

1 reference

7 June 2018

Tetsuro Setoyama

3

Tetsuro Setoyama

1 reference

7 June 2018

Lucilla D'Abundo

10

Lucilla D'Abundo

1 reference

7 June 2018

Vivian Ruvolo

20

Vivian R Ruvolo

1 reference

7 June 2018

author name string

Simona Rossi

13

1 reference

7 June 2018

Fortunato Morabito

17

1 reference

7 June 2018

Xuemei Wang

25

1 reference

7 June 2018

M James You

26

1 reference

7 June 2018

Tara M Lichtenberg

30

1 reference

7 June 2018

Massimo Negrini

33

1 reference

7 June 2018

language of work or name

English

0 references

publication date

30 November 2016

1 reference

7 June 2018

published in

Clinical Cancer Research

1 reference

7 June 2018

volume

23

1 reference

7 June 2018

issue

11

1 reference

7 June 2018

page(s)

2891-2904

1 reference

7 June 2018

Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNA-155 expression as a prognostic factor in patients with gallbladder carcinoma after surgical resection

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

8 June 2018

Cancer statistics, 2015

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNAome genome: a treasure for cancer diagnosis and therapy.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Tumour angiogenesis regulation by the miR-200 family

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Prognostic role of microRNA-155 in various carcinomas: results from a meta-analysis

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Clinical significance of microRNA-155 expression in human breast cancer

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

When mutants gain new powers: news from the mutant p53 field.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

miR-155 gene: a typical multifunctional microRNA.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

The resurgence of platinum-based cancer chemotherapy

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNA signatures in human cancers

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

A microRNA expression signature of human solid tumors defines cancer gene targets

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

The hyper-CVAD regimen in adult acute lymphocytic leukemia

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Genomic aberrations and survival in chronic lymphocytic leukemia

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Overexpression of microRNA-155 predicts poor prognosis in glioma patients.

8 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Overcoming resistance to targeted anticancer drugs.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5449263

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas

29 September 2018

1 reference

12 December 2020

Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155

1 reference

12 December 2020

The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab

1 reference

12 December 2020

MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management.

1 reference

12 December 2020

10.1158/1078-0432.CCR-16-1025

Identifiers

DOI

1 reference

7 June 2018

PMCID

5449263

1 reference

7 June 2018

PubMed ID

27903673

1 reference

7 June 2018